$VIR

$11.57 +$0.53 (4.8%) Close

$VIR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$VIR Management Team

Dr. Marianne De Backer

President

Chief Executive Officer

Age 56

Compensation $9.256M USD

Sex Female

Dr. Maninder Hora

Executive Vice President

Chief Technical Operations Officer

Age -

Compensation -

Sex Male

Dr. Mark Eisner

Executive Vice President

Chief Medical Officer

Age 61

Compensation $2.756M USD

Sex Male

Dr. Vicki Sato

Independent Chairman of the Board

Age 76

Compensation $295.6K USD

Sex Female

Mr. Jason O'byrne

Chief Financial Officer

Executive Vice President

Age 56

Compensation $1.920M USD

Sex Male

Ms. Vanina De Verneuil

Executive Vice President

General Counsel

Corporate Secretary

Age 46

Compensation $1.669M USD

Sex Female

Name / Title	Age	Compensation	Sex
Dr. Marianne De Backer President Chief Executive Officer	56	$9.256M USD	Female
Dr. Maninder Hora Executive Vice President Chief Technical Operations Officer	-	-	Male
Dr. Mark Eisner Executive Vice President Chief Medical Officer	61	$2.756M USD	Male
Dr. Vicki Sato Independent Chairman of the Board	76	$295.6K USD	Female
Mr. Jason O'byrne Chief Financial Officer Executive Vice President	56	$1.920M USD	Male
Ms. Vanina De Verneuil Executive Vice President General Counsel Corporate Secretary	46	$1.669M USD	Female

Board of Directors

From the proxy statement filed Apr 16, 2026

Directors

serving now

Independent

7 of 7

stated in the proxy; 2 not stated

Average tenure

5.2 years

from year joined

CEO also chairs the board

Jeffrey S. Hatfield and Vicki Sato

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Marianne De Backer CEO	57	2023 3 years	Not stated	None stated	None stated	Paid as CEO
Norbert Bischofberger	70	2024 2 years	Independent	Compensation Science and Technology	None stated	Not stated
Ramy Farid	61	2024 2 years	Independent	Audit Science and Technology	Schrödinger, Inc.	Not stated
Jeffrey S. Hatfield Board chair	68	2020 6 years	Independent	Audit Nominating and Corporate Governance · Chair	None stated	$184,645
Saira Ramasastry	50	2019 7 years	Independent	Audit · Chair	Mirum Pharmaceuticals, Inc. (2022 – present)	$180,126
Robert More	58	2016 10 years	Independent	Audit Compensation · Chair	Tyra Biosciences, Inc. (Chairman) (2021 – present)	$182,860
Janet Napolitano	68	2020 6 years	Independent	Compensation Nominating and Corporate Governance	Fortinet, Inc. (2024 – present)	$159,975
Elliott Sigal	74	2020 6 years	Independent	Compensation Science and Technology · Chair	Alnylam Pharmaceuticals, Inc. (2022 – present)	Not stated
Vicki Sato Leaving at the meeting Board chair	Not stated	Not stated	Not stated	None stated	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 16, 2026

GSK

Amount not stated

2023

Amendments No. 2 and No. 3 to the 2020 GSK collaboration agreement, removing the CoV Vaccine Program and modifying the coronavirus antibody program, with tiered royalties payable to GSK.

With Glaxo Wellcome UK Limited (GW) and GlaxoSmithKline Biologicals S.A. (GSK Bio) Open in proxy

GSK

Amount not stated

2024

Letter Agreement terminating the collaboration on the Influenza Program under the Definitive Collaboration Agreement, with royalty payments to GW on certain influenza products.

With Glaxo Wellcome UK Limited (GW) Open in proxy

Comments

Company Executives

$VIR Management Team

Dr. Marianne De Backer

Dr. Maninder Hora

Dr. Mark Eisner

Dr. Vicki Sato

Mr. Jason O'byrne

Ms. Vanina De Verneuil

Board of Directors

Related-party transactions